Neurostimulation Devices Market Analysis

Neurostimulation Devices Market Analysis

by Product, Application Type (Pain Management, Epilepsy, Essential Tremor, Urinary and Fecal Incontinence, Depression, Dystonia, Gastroparesis, Parkinson's Disease) Type and End User: Forecast to 2026

www.reportsanddata.com

Neurostimulation Devices Market: An Overview

Free Report Sample @ https://www.reportsanddata.com/sample-enquiry-form/2303 Neurostimulation Devices Market Dynamics The rising prevalence of chronic diseases and lifestyle health disorders, unmet needs of patients are stimulating technological development while shifting the significant focus of healthcare companies on the development of new mechanisms, patent expiry, availability of private and public funds for research, and supportive regulatory scenario.

www.reportsanddata.com

According to the current analysis of Reports and Data, the Global Neurostimulation Devices Market was valued at USD 5.59 Billion in 2019 and is expected to reach USD 14.27 Billion by the year 2027, registering a CAGR of 12.4 %. Neurostimulator or neurostimulation is equipment that is used for neuromodulation. The neuromodulation process uses an implantable medical device to alter neural activities for therapeutic purposes. The recent emergence of neurostimulation devices as a neural activity modulator is a major disruptive discovery in the healthcare sector. In line with this, neurostimulation devices market leaders, as well as emerging players, are developing machines that can be used for neural activity modulation. For instance, Medtronic, the U.S.-based medical device company, launched Enterra II gastric neurostimulator, a device that can be programmed to generate mild electrical pulses for gastric electrical stimulation to treat chronic nausea and vomiting due to gastroparesis.

These are some of the notable factors boosting the market growth. The launch of new devices is expected to support market growth over the coming years. For instance, Medtronic developed its pain neurostimulation system integrating the FDA-approved SureScan MRI Technology, which is engineered for patients to safely undergo an MRI scan.

Of the various types of neurostimulation devices, sacral nerve stimulators are expected to be the fastestgrowing market segment during the forecast period 2020-2027, with a CAGR of 13.2%. However, associated stringent government regulation is a major challenge for the Neurostimulation Devices market growth of this market segment Neurostimulation Devices Market: Regional Outlook The Asia Pacific region is expected to account for a 19.4% share of the global neurostimulation devices market. Developing nations such as China and India are expected to witness high growth of the market.

Europe is anticipated to hold 30.6% of the market share by the year 2027, with the regional segment is expected to grow at a CAGR of 12.1% over the forecast period.

www.reportsanddata.com

The American Academy of Neurology lists stroke as the third leading cause of death in the U.S., with Alzheimer’s ranking sixth. Statistics from reliable sources indicate that Parkinson’s affects nearly 1 million Americans annually, with at least a minimum of 60,000 new cases being reported annually, factors that will necessitate the neurostimulation devices market.

Prominent players in the Global Plant Growth Regulators Market: • • • • • • •

PLC, BioControl Medical St. Jude Medical Spinal Modulation Boston Scientific Corp.

Synapse Biomedical, Inc. Cochlear, Cyberonics, Inc. Nevro Corp.

The outbreak of COVID-19 has impacted many aspects of business, and the healthcare sector has been the most affected by the crisis. The World Health Organization has declared COVID-19 to be a global pandemic, and the healthcare industry has to undertake a number of emergency steps to help the general public fight with the deadly disease. While hospitals and clinics have been filled to capacity, trying to help ailing patients, most patients have been told to avoid healthcare institutions if not faced with an utter emergency as hospitals are highly contagious places. The neurostimulation devices market is expected to register a slowdown as neurological disorders are not ailments that can prove to be immediately life-threatening. But the market will once again pick up its growth pace as things get back to normal after the pandemic is finally over.

www.reportsanddata.com

Impact of COVID-19 on Neurostimulation Devices Market

Report Highlights: Detailed overview of the parent market Changing neurostimulation devices market dynamics In-depth neurostimulation devices market segmentation Historical, present, and projected neurostimulation devices market size in terms of volume and Recent neurostimulation devices market trends and developments Competitive landscape Strategies of key players and products offered Segments, sub-segments, and geographical regions showing growth prospects A neutral perspective on neurostimulation devices market performance

Browse Complete devices-market

Report @ https://www.reportsanddata.com/report-detail/neurostimulation-

Neurostimulation Devices Market: Segmentation This report forecasts revenue growth at global, regional, and country levels to provide an analysis of market trends in each of the sub-segments from 2017 to 2027. For the purpose of this report, Reports and Data has segmented the Neurostimulation Devices Market on the basis of product type, application type, type, end-use, and region:

www.reportsanddata.com

• • • • value • • • • •

Application Type (Revenue, USD Million; 2017–2027) • Pain Management • Epilepsy • Essential Tremor • Urinary and Fecal Incontinence • Depression • Dystonia • Gastroparesis • Parkinson’s Disease • Others Type (Revenue, USD Million; 2017–2027) • Implantable • External

www.reportsanddata.com

Product Type (Revenue, USD Million; 2017–2027) • Spinal Cord Stimulators • Deep Brain Stimulators • Sacral Nerve Stimulators • Vagus Nerve Stimulators • Gastric Electric Stimulators

Regional Outlook (Revenue in USD Million; 2017–2027) • North America o U.S. o Canada o Mexico • Europe o Germany o France o U.K. o Spain o Benelux o Italy o Rest of Europe • Asia Pacific o China o India

www.reportsanddata.com

End-Use (Revenue, USD Million; 2017–2027) • Hospitals/Clinics • Cognitive Care Centers • Research Institutes • Others

• o o o • o o o o o

Japan South Korea Taiwan Australia Rest of Asia Pacific Latin America Brazil Argentina Rest of Latin America Middle East & Africa Saudi Arabia South Africa Egypt Israel Rest of MEA

www.reportsanddata.com

o o o o o

About Us Reports and Data is a market research and

We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact US John Watson Head of Business Development Reports And Data | Web: www.reportsanddata.com Direct Line: +1-212-710-1370 E-mail: sales@reportsanddata.com

www.reportsanddata.com

consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision.